Works matching IS 2160763X AND DT 2022 AND VI 11 AND IP 2

Results: 15

Effect of Pantoprazole on the Absorption of Hydroxychloroquinea A Randomized Drug‐Drug Interaction Trial in Healthy Adults.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 2, p. 285, doi. 10.1002/cpdd.999

By:

Stoll, Felicitas;
Blank, Antje;
Mikus, Gerd;
Czock, David;
Foerster, Kathrin I.;
Hermann, Simon;
Gümüs, Katja;
Muhareb, Amin;
Hummler, Simone;
Sauter, Max;
Weiss, Johanna;
Burhenne, Jürgen;
Haefeli, Walter E.

Publication type:

Article

Evaluation of the Pharmacokinetic Interaction and Safety of Ubrogepant Coadministered With Esomeprazole Magnesium.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 2, p. 270, doi. 10.1002/cpdd.1034

By:

Boinpally, Ramesh;
Lu, Kaifeng

Publication type:

Article

Population Pharmacokinetic Modeling and Exposure‐Response Analysis for Aripiprazole Once Monthly in Subjects With Schizophrenia.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 2, p. 150, doi. 10.1002/cpdd.1022

By:

Wang, Xiaofeng;
Raoufinia, Arash;
Bihorel, Sébastien;
Passarell, Julie;
Mallikaarjun, Suresh;
Phillips, Luann

Publication type:

Article

Bioequivalence Evaluation Between Acarbose and Metformin Fixed‐Dose Combination and Corresponding Individual Components in Healthy Chinese Male and Female Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 2, p. 173, doi. 10.1002/cpdd.994

By:

Liu, Chao;
Cleton, Adriaan;
Sui, Yubin;
Liu, Yuwang;
Li, Jinyi;
Yuan, Fei;
Sheng, Lei;
Xu, Hongrong;
Li, Xuening

Publication type:

Article

Issue Information.

Published in:: Clinical Pharmacology in Drug Development, 2022, v. 11, n. 2, p. 137, doi. 10.1002/cpdd.824
Publication type:: Article

Pharmacokinetics of Asciminib When Taken With Imatinib or With Food.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 2, p. 207, doi. 10.1002/cpdd.1019

By:

Hoch, Matthias;
Zack, Julia;
Quinlan, Michelle;
Huth, Felix;
Forte, Sofia;
Dodd, Stephanie;
Aimone, Paola;
Hourcade‐Potelleret, Florence

Publication type:

Article

A Randomized Phase 1 Evaluation of Deupirfenidone, a Novel Deuterium‐Containing Drug Candidate for Interstitial Lung Disease and Other Inflammatory and Fibrotic Diseases.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 2, p. 220, doi. 10.1002/cpdd.1040

By:

Chen, Michael C.;
Korth, Christopher C.;
Harnett, Mark D.;
Elenko, Eric;
Lickliter, Jason D.

Publication type:

Article

Pharmacokinetic Modeling of Ketamine Enantiomers and Their Metabolites After Administration of Prolonged‐Release Ketamine With Emphasis on 2,6‐Hydroxynorketamines.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 2, p. 194, doi. 10.1002/cpdd.993

By:

Weiss, Michael;
Siegmund, Werner

Publication type:

Article

Pharmacokinetic Evaluation of the CYP3A4 and CYP2D6 Drug‐Drug Interaction and CYP3A4 Induction Potential of Omecamtiv Mecarbil: Two Open‐Label Studies in Healthy Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 2, p. 185, doi. 10.1002/cpdd.987

By:

Trivedi, Ashit;
Malik, Fady I.;
Jafarinasabian, Pegah;
Zhang, Hanze;
Flach, Stephen;
Abbasi, Siddique;
Dutta, Sandeep;
Lee, Edward

Publication type:

Article

Pharmacokinetics and Metabolism of Ziritaxestat (GLPG1690) in Healthy Male Volunteers Following Intravenous and Oral Administration.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 2, p. 246, doi. 10.1002/cpdd.1021

By:

Helmer, Eric;
Willson, Ashley;
Brearley, Christopher;
Westerhof, Mark;
Delage, Stephane;
Shaw, Iain;
Cooke, Ray;
Sidhu, Sharan

Publication type:

Article

Evaluation of the Pharmacokinetics of Felcisetrag (TAK‐954), a 5‐HT<sub>4</sub> Receptor Agonist, in the Presence and Absence of Itraconazole, a Potent CYP3A4 Inhibitor.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 2, p. 142, doi. 10.1002/cpdd.1046

By:

Chen, Chunlin;
Zhang, Liming;
Almansa, Cristina;
Rosario, Maria;
Cwik, Michael;
Balani, Suresh K.;
Lock, Ruth

Publication type:

Article

Pharmacokinetic, Safety, and Pharmacodynamic Properties of Teverelix Trifluoroacetate, a Novel Gonadotropin‐Releasing Hormone Antagonist, in Healthy Adult Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 2, p. 257, doi. 10.1002/cpdd.1008

By:

MacLean, Carol M.;
Godsafe, Zona;
Soto‐Forte, Pablo;
Larsen, Finn

Publication type:

Article

Pharmacokinetic and Bioequivalence Evaluation of 2 Tadalafil Tablets in Healthy Male Chinese Subjects Under Fasting and Fed Conditions.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 2, p. 165, doi. 10.1002/cpdd.1007

By:

Shao, Rong;
Yang, Dan‐dan;
Ruan, Zou‐rong;
Chen, Jin‐liang;
Hu, Yin;
Jiang, Bo;
Lou, Hong‐gang

Publication type:

Article

Assessment of the Effect of Filgotinib on the Pharmacokinetics of Atorvastatin, Pravastatin, and Rosuvastatin in Healthy Adult Participants.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 2, p. 235, doi. 10.1002/cpdd.1015

By:

Anderson, Kacey;
Nelson, Cara H.;
Gong, Qi;
Alani, Muhsen;
Tarnowski, Thomas;
Othman, Ahmed A.

Publication type:

Article

The Effect of Food on the Pharmacokinetics of the Potassium‐Competitive Acid Blocker Vonoprazan.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 2, p. 278, doi. 10.1002/cpdd.1009

By:

Mulford, Darcy J.;
Leifke, Eckhard;
Hibberd, Mark;
Howden, Colin W.

Publication type:

Article